Mammographic surveillance in women younger than 50 years who have a family history of breast cancer: Tumour characteristics and projected effect on mortality in the prospective, single-arm, FH01 study

The Lancet Oncology

Volumn 11, Issue 12, 2010, Pages 1127-1134

  Duffy, Stephen W ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BREAST CANCER; CANCER EPIDEMIOLOGY; CANCER GRADING; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; CANCER STAGING; COHORT ANALYSIS; CONTROLLED STUDY; FAMILIAL CANCER; FAMILY HISTORY; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; POPULATION RESEARCH; PRIORITY JOURNAL; PROGNOSIS; UNITED KINGDOM;

ADULT; AGE FACTORS; BREAST NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; NEOPLASM STAGING; SENSITIVITY AND SPECIFICITY;

EID: 78649591306     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(10)70263-1     Document Type: Article

References (29)

1. Miki Y, Swensen J, Shattuck-Eidens D, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994, 266:66-71.
2. Wooster R, Bignell G, Lancaster J, et al. Identification of the breast cancer susceptibility gene BRCA2. Nature 1995, 378:789-792.
3. Metcalfe KA, Birenbaum-Carmeli D, Lubinski J, et al. International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers. Int J Cancer 2008, 122:2017-2022.
4. Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS). Lancet 2005, 365:1769-1778. MARIBS study group.
5. McIntosh A, Shaw C, Evans G, et al. Clinical guidelines and evidence review for the classification and care of women at risk of familial breast cancer 2004, National Institute for Health and Clinical Excellence, London, update 2006.
6. The challenge of evaluating annual mammography screening for young women with a family history of breast cancer. J Med Screen 2006, 13:177-182. FH01 management committee, steering committee and collaborators.
7. Maurice A, Evans DGR, Shenton A, et al. Screening younger women with a family history of breast cancer-does early detection improve outcome?. Eur J Cancer 2006, 42:1385-1390.
8. Moss S, Waller M, Anderson TJ, Cuckle H Randomised controlled trial of mammographic screening in women from age 40: predicted mortality based on surrogate outcome measures. Br J Cancer 2005, 92:955-960.
9. Brekelmans CTM, Tilanus-Linthorst MMA, Seynaeve C, et al. Tumour characteristics, survival and prognostic factors of hereditary breast cancer from BRCA2-, BRCA1- and non-BRCA1/2 families as compared to sporadic breast cancer cases. Eur J Cancer 2007, 43:867-876.
10. Tyndel S, Clements A, Bankhead C, et al. Mammographic screening for young women with a family history of breast cancer: knowledge and views of those at risk. Br J Cancer 2008, 99:1007-1012.
11. Brain K, Henderson BJ, Tyndel S, et al. Predictors of breast cancer-related distress following mammography screening in younger women on a family history breast screening programme. Psychooncology 2008, 17:1180-1188.
12. Tyndel S, Austoker J, Henderson BJ, et al. What is the psychological impact of mammographic screening on younger women with a family history of breast cancer? Findings from a prospective cohort study by the PIMMS Management Group. J Clin Oncol 2007, 25:3823-3830.
13. Henderson BJ, Tyndel S, Brain K, et al. Factors associated with breast cancer-specific distress in younger women participating in a family history mammography screening programme. Psychooncology 2008, 17:74-82.
14. Tabar L, Fagerberg G, Duffy SW, Day NE, Gad A, Grontoft O Update of the Swedish two-county program of mammographic screening for breast cancer. Radiol Clin North Am 1992, 30:187-210.
15. Tabar L, Vitak B, Chen HH, Duffy SW, Smith RA The Swedish two-county trial twenty years later: updated mortality results and new insights from long term follow-up. Radiol Clin North Am 2000, 38:625-651.
16. Blamey RW, Ellis IO, Pinder SE, et al. Survival of invasive breast cancer according to the Nottingham prognostic index in cases diagnosed in 1990-99. Eur J Cancer 2007, 43:1548-1555.
17. Tyrer J, Duffy SW, Cuzick J A breast cancer prediction model incorporating familial and personal risk factors. Stat Med 2004, 23:1111-1130.
18. Casella G, Berger RL Statistical inference 2002, Duxbury Press, Belmont, CA.
19. Young KC, Burch A, Oduko JM Radiation doses received in the UK Breast Screening Programme in 2001 and 2002. Br J Radiol 2005, 78:207-218.
20. Lawrence G, O'Sullivan E, Kearins O, Tappenden N, Martin K, Wallis M Screening histories of invasive breast cancers diagnosed 1989-2006 in the West Midlands, UK: variation with time and impact on 10-year survival. J Med Screen 2009, 16:186-192.
21. Breast-cancer screening with mammography in women aged 40-49 years. Int J Cancer 1996, 68:693-699. Organising Committee and Collaborators, Falun meeting, Falun, SwedenFalun meeting, Falun, Sweden.
22. Moss SM, Cuckle H, Evans A, Johns L, Waller M, Bobrow L Effect of mammographic screening from age 40 years on breast cancer mortality at 10 years' follow-up: a randomised controlled trial. Lancet 2006, 368:2053-2060. for the Trial Management Group.
23. Pinder SE, Wencyk PM, Naylor HE, et al. The assessment of multiple variables on breast carcinoma fine needle aspiration (FNA) cytology specimens: method, preliminary results and prognostic associations. Cytopathology 1995, 6:316-324.
24. Dawson SJ, Duffy SW, Blows FM, et al. Molecular characteristics of screen detected vs symptomatic breast cancers and their impact on survival. Br J Cancer 2009, 101:1338-1344.
25. Kriege M, Brekelmans CT, Boetes C, et al. Efficacy of MRI and mammography for breast cancer screening in women with a familial or genetic predisposition. N Engl J Med 2004, 351:427-437.
26. Kuhl CK, Schrading S, Leutner CC, et al. Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. J Clin Oncol 2005, 23:8469-8476.
27. Warner E, Plewes DB, Hill KA, et al. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography and clinical breast examination. JAMA 2004, 292:1317-1325.
28. Antoniou AC, Cunningham AP, Peto J, et al. The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions. Br J Cancer 2008, 98:1457-1466.
29. Young KC Radiation doses in the United Kingdom trial of breast screening in women aged 40-48 years. Br J Radiol 2002, 75:362-370.